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Antibiotic disk susceptibility tests were done on 220 strains of Escherichia coli
belonging to serotypes reported in the literature to be associated with the
production of enterotoxin. A total of 128 (58%) were resistant to one or more
antibiotics, sulfa drugs, or chemotherapeutic agents. An analysis of these strains
revealed primary, secondary, and tertiary drug resistance patterns that mdicated
a selective pattern in the formation of multiple drug resistance in E. coli.
Resistances to certain antibiotics were more likely to occur in pairs and triads
(secondary resistance patterns) that were often combined or coexisted in a single
strain of E. coli to produce tertiary drug resistance patterns, conferring drug
resistance to five or six different antibiotics. Among enterotoxin-associated sero-
types, single and multiple drug resistance was less frequently associated with
enterotoxin-producing strains than with strains from the same serotype that were
not enterotoxigenic. Within the enterotoxigenic E. coli, single and multiple
resistance to antibiotics was more frequent in strains producing only heat-stable
enterotoxin (ST) than in strains producing only heat-labile enterotoxin (LT) or
both. The number of resistances to different antibiotics per resistant strain
averaged approximately 1.4 for LT plus ST or LT strains, and 3.9 for ST strains
and nonenterotoxigenic strains. Phenotypic characterization of 170 strains for
four usually plasmid-mediated characteristics showed that the number of anti-
biotics to which a strain was directly resistant varied with the type and number
of plasmid-mediated characteristics present.
Enterotoxigenic Escherichia coli (ETEC)
have been implicated in sporadic cases and epi-
demic outbreaks of diarrhea in both infants and
adults in many parts of the world (4, 21, 29, 31,
33). ETEC produce one or both of two plasmid-
mediated enterotoxins (18, 37): a heat-stable en-
terotoxin (ST) and a heat-labile enterotoxin
(LT). The plasmid genes that control entero-
toxin production occupy only a small portion of
the total plasmid genome (7, 39). To delineate
pathogenic mechanisms and their transmissibil-
ity in ETEC, it would be useful to study other
traditionally plasmid-mediated characteristics
associated or compatible with the enterotoxin
(Ent) plasmids. Other plasmids that might co-
exist in the same cell with Ent include those
with genes coding for antibiotic resistance (1, 3,
17, 19, 20, 41), colonization factors (CFs) (13, 14,
26, 38), and a filterable, heat-labile hemolytic
entity (HLY1) (16, 25, 37). Antibiotic disk sus-
ceptibility tests were done on 220 strains of E.
coli belonging to serotypes previously reported
in the literature to be associated with entero-
toxin production (enterotoxin-associated sero-
types). This study was undertaken to determine
the prevalence of antibiotic resistance in these
strains and to investigate possible associations
between antibiotic resistance and other plasmid-
mediated characteristics indicating virulence.
(This work is a portion of a dissertation sub-
mitted by J. D. to the University of North
Carolina in partial fulfilunent of the requirement
for the degree of Doctor of Public Health in the
School of Public Health.)
MATERIALS AND METHODS
All 220 strains of E. coli were received by the
Enteric Section, Bacteriology Division, Center for Dis-
ease Control between 1960 and 1978. They were ini-
tially rejuvenated by culturing on Trypticase soy agar
plates before being transferred to and maintained on
blood agar base slants at room temperature.
Antibiotic susceptibility tests for 12 antibiotics were
done according to the standard disk diffusion tech-
niques recommended in the Manual of Clinical Mi-
crobiology (22). The disks (BBL Sensi-disk) used were:
colistin (CL1O), streptomycin (S10), cephalothin
(CF30), gentamicin (GM1O), nalidixic acid (NA30),
kanamycin (K30), tetracycline (TE30), chloramphen-
icol (C30), rifampin (RA5), ampicillin (AM10), carben-
icillin (CB100), and sulfadiazine (SD250). These anti-
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bioties were chosen on the basis of their clinical and
genetic relevance and their use as epidemiological
markers.
Of the 220 enterotoxin-associated serotype strains,
170 were assayed for four plasmid-mediated charac-
teristics: ST, LT, CFs, and a filterable, heat-labile
hemolytic activity (HLY1). The tests for ST and LT
were the infant mouse assay (8, 15) and the Y1 adrenal
cell assay (10, 30), respectively. The assays for CFs
consisted of hemagglutination tests with human and
bovine erythrocytes (11, 12, 14, 27) and a micro-pre-
cipitation test (C. F. Deneke, G. M. Thorne, and S. L.
Gorbach, Abstr. 15th Joint Conf. on Cholera, U. S.-
Japan Coop. Med. Sci. Prog. 1979, p. 35-36) with
specific anti-pili sera (9) that were supplied by Grace
Thorne, New England Medical Center, Boston, Mass.
Screening tests for hemolytic activity were done in
liquid saline-peptone medium and in horse erythrocyte
agar plates according to the methods of Cooke (6), and
a specific assay for the presence of HLY1 was done,
with minor modifications (8a), according to the basic
procedures of Smith (36) and Short and Kurtz (34).
RESULTS
Of 220 strains of E. coli belonging to entero-
toxin-associated serotypes, 128 (58%) were re-
sistant to at least 1 of 12 antibiotics. The number
of strains resistant to a single antibiotic ranged
from 65 (30%) for sulfadiazine to none for gen-
tamicin and colistin. A survey of multiple drug
resistance among these 128 strains provided the
data in Fig. 1 and 2. In Fig. 1 the conditional
probability of finding resistance to a second an-
tibiotic (listed vertically), when resistance to a
first antibiotic (listed horizontally) already ex-
ists, is given for any pair of antibiotics both as a
fraction (number of strains resistant to both the
first and second antibiotics divided by the num-
ber of strains resistant to only the first anti-
biotic) and as a percentage. A panorama of the
multiple drug resistance associations found
among all possible pairs ofantibiotics in multiply
drug-resistant strains is presented in Fig. 2. The
major antibiotic resistance patterns possessed
by multiply resistant strains are presented in
Fig. 3. Excluding the usually chromosomally
mediated drug resistance to rifampin and ceph-
alothin left 85 strains that were resistant to 2 or
more of 10 additional antibiotics. Of these 85, 65
(76%) were multiply resistant to two or more
antibiotics.
When all 220 test strains were sorted into
groups based on enterotoxin production, and the
percentages of strains resistant to individual an-
tibiotics were compared (Table 1), the group of
non-ETEC had higher percentages of drug-re-
sistant strains than did any group containing
ETEC. A subset of 65 human strains isolated in
the United States were similarly sorted and com-
pared (Table 2). Again the group of non-ETEC
possessed higher percentages of drug-resistant
strains than did any group containing ETEC.
The ETEC in this subset were found to harbor
significantly fewer strains expressing resistance
to three of eight antibiotics (Table 2). No ETEC
resistant to colistin, nalidixic acid, cephalothin,
or gentamicin were available for comparison in
this table.
Among the ETEC, strains producing ST alone
expressed drug resistances to more antibiotics
than did strains producing LT (Table 1). Further
comparison of antibiotic resistance with entero-
toxigenicity (Table 3) showed that the average
number of antibiotic resistances per resistant
strain was much lower for strains producing LT
plus ST or LT alone than for strains producing
ST alone or neither enterotoxin. ETEC produc-
ing ST alone were resistant to an average of four
different antibiotics. This average was as high as
that seen in the non-ETEC.
Table 4 compares antibiotic resistances among
170 strains of E. coli phenotypically character-
ized by the presence or absence of ST, LT, CFs,
and HLY1. A high ratio of antibiotic resistances
to resistant strains was found in strains lacking
all four plasmid-mediated characteristics and in
strains with the following phenotypic patterns:
ST, CF, and CF HLY1. Little drug resistance
was found in strains with patterns possessing
either LT (e.g., ST LT CF, ST LT, LT CF, or
LT alone) or CF in conjunction with an Ent
plasmid (e.g., ST LT CF, ST CF, or LT CF).
DISCUSSION
Seventy-six percent (65/85) of our resistant E.
coli were resistant to 2 or more of 10 antibiotics.
This data agrees with similar data recently re-
ported from Canada, where 60 to 70% ofresistant
E. coli were found to be insensitive to two or
more separate antibiotics (G. Bezanson and H.
Lior, Laboratory Center for Disease Control
Newsletter 1979-2, p. 15).
An analysis of all 128 strains ofE. coli showing
single or multiple drug resistance yielded the
primary, secondary, and tertiary drug resistance
patterns listed in Fig. 3, excluding an obviously
longer list of tertiary patterns. Our data indicate
that selection occurs in the formation ofmultiple
drug resistance in E. coli. Figures 1 and 2 show
that secondary drug resistance patterns were
most likely to occur between certain pairs of
antibiotics. For example, when resistance to sul-
fadiazine was present, 69% of all sulfadiazine-
resistant strains were also resistant to tetracy-
cline, and 71% of all tetracycline-resistant strains
were also sulfadiazine resistant (e.g., in Fig. 1:
TE given SD = 69%, SD given TE = 71%, CM
given KM = 67%, KM given CM = 75%). Other
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CF AM CB CM KM SD SM TE RA
aRA (rifampin), TE (tetracycline), SM (streptomycin), SD (sulfadiazine), KM (kanamycin),
CM (chloramphenicol), CB (carbenicillin), AM (ampicillin), CF (cephalothin).
bExamples of %: CB given AM = 88% (out of 40 ampicillin-resistant strains, 35 or 88% were
also carbenicillin resistant); AM given CB = 100%; SD given KM = 89%; KM given SD = 25%.
CPercentages of strains resistant to CF and RA (outer borders) serve as baseline percentages
since resistance to these antibiotics is usually chromosomally mediated.
FIG. 1. Antibiotic resistance associations between paired antibiotics in multiply resistant E. coli.
pairs, however, were found to be present most
often only when a particular one of the two
antibiotic resistances was present. For example,
when resistance to chloramphenicol was present,
92% of all chloramphenicol-resistant strains were
also resistant to sulfadiazine, but only 34% of all
sulfadiazine-resistant strains were also chlor-
amphenicol resistant (e.g., in Fig. 1: SD given
CM = 92%, but CM given SD = 34%; TE given
KM = 83%, but KM given TE = 24%). Certain
types of plasmids may contain recombination or
insertion sites for particular antibiotic resistance
genes. Furthermore, certain strains or serotypes
of E. coli may readily accept and maintain spe-
cific plasmids, or plasmids in general. This could
account for the apparent selection seen in the
formation of multiple drug resistance in partic-
ular strains of E. coli.
Secondary resistance patterns often combined
or coexisted in a single E. coli to yield the
tertiary resistance patterns listed in Fig. 3.
Whether the accumulation of plasmid-mediated
drug resistances to form large resistance patterns
is due to the accession of separate but compati-
ble plasmids each containing individual drug
resistance(s), or to an increase in the number of
transposable elements, each carrying a gene(s)
for drug resistance, within a single plasmid, is
not fully known. Nonetheless, it would seem
logical that the larger the complement of plas-
mid DNA possessed by a single cell, the greater
chance there is for insertion of drug resistance
transposons at sites within the plasmid(s).
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FIG. 2. Panorama of antibiotic resistance associ-



























FIG. 3. Primary, secondary, and tertiary antibiotic
resistancepatterns found among 128 strains ofsingly
and multiply resistant E. coli. Connecting lines join
multiple resistances.
those strains that produce either ST plus LT or
LT alone, are unusually susceptible to antibiot-
ics. The data presented in Tables 1 to 4 support
his statement. For three of the eight antibiotics
listed in Table 2 there were significantly fewer
drug resistances associated with ETEC than
with non-ETEC. And, as Tables 3 and 4 show,
among ETEC there was much less multiple drug
resistance associated with strains producing LT
plus ST, or LT alone, than with strains produc-
ing ST alone.
All of these data suggest possible interactions
and incompatibilities among resistance genes,
Ent genes, and the entire plasmid complement.
Genotypic studies are presently under way to
delineate some of these possible interactions;
however, some observations can be reported at
this time. Eleven strains lacking all four plasmid-
mediated characteristics still possessed a high
ratio of drug resistances per resistant strain (Ta-
ble 4). These drug resistances are probably car-
ried on otherwise cryptic plasmids which will be
evident with transfer studies and a plasmid pro-
file. Some antibiotic resistance genes are able to
move from genome to genome by a nonclassical
recombination event called transposition (5). It
is not surprising that we found more drug resis-
tances among ST-producing strains, since ST
has recently been reported (40) on a transposon
flanked by IS1 elements, an insertion sequence
homologous to the inverted repeats flanking
Tn9, the transposon known to carry chloram-
phenicol resistance (24). We surmise that a plas-
mid capable of accepting (inserting) ST into its
genome would also be capable of inserting the
gene(s) for chloramphenicol or possibly for other
drug resistances. This could form a single plas-
mid coding for both enterotoxin production and
drug resistance. McConnell et al. (23) recently
reported such a case in a human isolate of E.
coli which possessed a plasmid coding for ST,
LT, and resistance to ampicillin. In addition,
strains possessing an ST-mediating plasmid
might be more likely to accept or maintain not
only drug resistance plasmids but also other
compatible plasmids, such as CF and HLY1
(Table 4).
In ETEC-producing LT, however, we found
few strains resistant to antibiotics (Tables 2 to
4). The exception was sulfadiazine (Table 1),
which appears to be on a separate plasmid com-
patible with the LT Ent plasmid (V. Baselski,
personal communication). The low number of
antibiotic resistances associated with LT strains
of E. coli could be due to some basic incompat-
ibilities between LT Ent and R plasmids, or
there may be other mechanisms within the LT
Ent plasmid itself that are responsible. For ex-
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TABLE 1. Antibiotic resistance data' for 220 E. coli strains belonging to enterotoxin-associated serotypesb
No. of strains resistant (%)
Antibiotie Ail strains ST LT Non-ETEC
(n=220)' (n= 17) LT (n = 15) ST (n = 27) n-= 161)
Sulfadiazine 65 (30) 1 (6) 7 (47) 4 (15) 53 (33)
Tetracycline 64 (29) 2 (12) 2 (13) 6 (22) 54 (34)
Rifampin 62 (28) 4 (24) 3 (20) 5 (18) 50 (31)
Streptomycin 49 (22) 0 (0) 1 (7) 3 (11) 45 (28)
AmpicilHin 40 (18) 0 (0) 0 (0) 2 (7) 38 (24)
Carbenicillin 35 (16) 0 (0) 0 (0) 2 (7) 33 (20)
Chloramphenicol 24 (11) 1 (6) 0 (0) 6 (22) 17 (11)
Kanamycin 18 (8) 0 (0) O (0) 5 (18) 13 (8)
Cephalothin 4 (2) 0 (0) 0 (0) 0 (0) 4 (2)
Nalidixic acid 2 (1) 0 (0) O (0) 0 (0) 2 (1)
Gentamicin 0 (0) 0 (0) O (0) 0 (0) 0 (0)
Colistin 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
<'Antibiotic susceptibility tests used BBL Sensi-disks CL10, S10, CF30, GM 10, NA30, K30, TE30, C30, RA5,
AM10, CB100, and SD250.
b The enterotoxin-associated serotypes tested consisted of the following and were reported in the literature,
on at least two occasions before July 1978, to contain enterotoxigenic strains: 06:H16, 06:H-, 08:H9, 08:H?,
015:H11, 015:H-, 020:H-, 025:H-, 027:H20, 078:H11, 078:H12, 0128:H7, 0128:H12, 0128:H21, 0148:H28, and
0149:H19.
C n, Number of strains tested.
TABLE 2. Antibiotic resistances in 65 human E. coli
strains isolated within the United States between 1960
and 1978
No. of strains re-
sistant (%)
Antibiotic resis- Probability of
tance' ETEC Non- chance
ETEC28 ETEC
(n = 28) (n = 37)
Tetracycline 6 (21) 17 (46) NS
Streptomycin 3 (11) 16 (43) x2 = 6.66, P < 0.01
Rifampin 7 (25) 15 (40) NS
Sulfadiazine 7 (25) 14 (38) NS
Ampicillin 1 (4) 13 (35) x2 = 7.62, P < 0.01
Carbenicillin 1 (4) 13 (35) x2 = 7.62, P < 0.01
Chloramphenicol 4 (14) 7 (19) NS
Kanamycin 2 (7) 5 (14) NS
a No ETEC were found to be resistant to colistin, nalidixic
acid, cephalothin, or gentamicin; no non-ETEC were found to
be resistant to colistin or gentamicin.
b Probability that the observed difference is due to chance
alone. Al] probabilities are based on two-sample chi-square
tests for significance. NS, Not significant.
ample, an LT Ent plasmid may lack the neces-
sary insertion site(s) for drug resistance trans-
posons, or if LT itself were a transposon, it could
possibly prevent acquisition of a second trans-
poson (28), a mechanism referred to as transpo-
sition immunity (2). It is also possible that LT
Ent plasmids do insert transposons for drug
resistance and that such insertions interfere with
the expression of the LT gene. Regardless of
mechanism, it would appear that there is less
risk of accumulating drug-resistant ETEC when
LT-induced, rather than ST-induced, diarrhea
is treated with antibiotics. However, it is pres-
TABLE 3. Antibiotic resistance of 85 drug-resistant
E. coli strains, by enterotoxin production
Total no.
of anti- Total
bioties to no.l Avg no. of




ST LT 4 3 1.33
LT 10 7 1.42
ST 28 7 4.00
Non-ETEC 255 68 3.75
a Totals do not include resistance to rifampin or
cephalothin because resistance to these drugs is usu-
ally chromosomally rather than plasmid mediated.
ently impractical for most clinical laboratories
to determine which toxin or toxin genes are
responsible for a case of diarrhea. Therefore,
there is no way to adequately differentiate be-
tween LT- and ST-induced cases for treatment
purposes.
This discussion has important implications for
the treatment of ETEC diarrhea with antibiot-
ics. Since all ETEC possess at least one plasmid
(Ent), which has been demonstrated on at least
one occasion (23) to carry drug resistance genes,
it is possible that dissemination of Ent could
occur under the force of selective antibiotic pres-
sure, either in the laboratory or in therapy (29).
CF plasmids are often found associated with
ETEC, and, from the data presented in Table 4,
it appears that this additional plasmid may also
harbor genes for drug resistance.
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TABLE 4. Antibiotic resistance among 170
phenotypically characterized E. coli strains sorted
by phenotypic pattern
No. of resistant Total no. of Avg no.
s.8trains/no of antibiotic of resis-Pattern strain8tesd resstances/ tances5trainteste no. of per
strains strain
ST LT CF 0/6 (0) 0/0 0.00
ST LT 3/12 (25) 4/3 1.33
LT CF 5/8 (62) 7/5 1.40
LT 2/7 (29) 3/2 1.50
STCF 1/8 (12) 2/1 2.00
HLY1 6/14 (43) 12/6 2.00
Noneb 11/37 (30) 38/11 3.45
CF 26/49 (53) 103/26 3.96
ST 5/19 (26) 20/5 4.00
CF HLY1 4/10 (40) 17/4 4.25
a Totals do not include drug resistances to rifampin
or cephalothin.
b Absence of all four plasmid-mediated characteris-
tics.
One conclusion is that the more plasmid DNA
a microorganism possesses, the greater is its
chance of possessing drug resistance; and, since
ETEC usually possess a number of plasmids,
ETEC have a better than average chance of
expressing drug resistance. A second conclusion
is that ETEC diarrhea should not be treated
with antibiotics because a positive selective pres-
sure might be induced by an antibiotic which
would not only fail to eliminate the ETEC but
actually increase their number and prolong their
normally short duration. ETEC diarrhea in
adults is usually a self-limited disease entity
requiring rehydration at most (31).
Six strains possessing the ST LT CF pheno-
typic pattern expressed no drug resistance. The
significance of this finding is not apparent, but
it is known that the ST gene(s) can insert into
a CF plasmid (40). In the near future, LT gene(s)
may also be found on a transposon (35). Theo-
retically, if a CF plasmid possessed one or a few
insertion sites for commonly occurring transpo-
sons, this site or sites could be filled by the ST
or LT genes or both. Then we could expect to
find few or no sites remaining for antibiotic
transposons. It is interesting (Table 4) that
strains with the CF-only phenotypic pattern pos-
sessed an average of 3.96 resistances to antibiot-
ics, whereas strains with CF ST and CF LT
patterns possessed 2 and 1.4 different antibiotic
resistances, respectively. As stated above, strains
with the CF ST LT pattern showed no antibiotic
resistances.
Further phenotypic and genotypic studies
should also be carried out to determine whether
there are associations between particular resis-
tance patterns and particular plasmids. Should
such associations exist, they may lead to a pos-
sible screening assay, based on antibiotic suscep-
tibility testing, for the presence or absence of
plasmids implicated in the pathogenicity of E.
coli.
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